FDA Inspection 1303192 — Wockhardt Bio Ag
The FDA completed an inspection of Wockhardt Bio Ag on Jan 23, 2026 in Zug. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 23, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Zug (Switzerland)
Additional details
Sponsor, Contract Research Organization